Rapamycin promotes the intestinal barrier repair in ulcerative colitis via the mTOR/PBLD/AMOT signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapamycin promotes the intestinal barrier repair in ulcerative colitis via the mTOR/PBLD/AMOT signaling pathway

Published:2024-10 Issue:7 Volume:1870 Page:167287
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Xu Yan,Ou Jinyuan,Zhang Chuhong,Chen Jiayue,Chen Junsheng,Li Aimin,Huang Bing,Zhao Xinmei

Funder

Basic and Applied Basic Research Foundation of Guangdong Province

Southern Medical University

National Natural Science Foundation of China

Southern Medical University Nanfang Hospital

Publisher

Elsevier BV

Reference41 articles.

1. Has the incidence of inflammatory bowel disease peaked? Evidence from the population-based NorDIBD cohort 1978–2020;Larsen;Am. J. Gastroenterol.,2023

2. Landscape and predictions of inflammatory bowel disease in China: China will enter the compounding prevalence stage around 2030;Shao;Front. Public Health,2022

3. Ulcerative colitis;Ordas;Lancet,2012

4. Ulcerative colitis;Kobayashi;Nat. Rev. Dis. Primers,2020

5. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort;Vegh;J. Crohns Colitis,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP